3.33
+0.3(+9.90%)
Currency In USD
| Previous Close | 3.03 |
| Open | 3.09 |
| Day High | 3.35 |
| Day Low | 3.09 |
| 52-Week High | 6.2 |
| 52-Week Low | 1.33 |
| Volume | 232,587 |
| Average Volume | 53,053 |
| Market Cap | 32.85M |
| PE | -3.17 |
| EPS | -1.05 |
| Moving Average 50 Days | 2.64 |
| Moving Average 200 Days | 2.47 |
| Change | 0.3 |
NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
GlobeNewswire Inc.
Sep 18, 2025 12:00 PM GMT
CARMEL, Ind., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
GlobeNewswire Inc.
Aug 05, 2025 12:30 PM GMT
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
GlobeNewswire Inc.
Jun 17, 2025 12:00 PM GMT
CARMEL, Ind., June 17, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children a